You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

ZANTAC 25 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zantac 25 patents expire, and what generic alternatives are available?

Zantac 25 is a drug marketed by Glaxo Grp Ltd and is included in one NDA.

The generic ingredient in ZANTAC 25 is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.

Drug patent expirations by year for ZANTAC 25
Recent Clinical Trials for ZANTAC 25

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Spaulding Clinical Research LLCPhase 1
Food and Drug Administration (FDA)Phase 1
Nova Scotia Health AuthorityPhase 4

See all ZANTAC 25 clinical trials

US Patents and Regulatory Information for ZANTAC 25

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxo Grp Ltd ZANTAC 25 ranitidine hydrochloride TABLET, EFFERVESCENT;ORAL 020251-003 Apr 1, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ZANTAC 25

See the table below for patents covering ZANTAC 25 around the world.

Country Patent Number Title Estimated Expiration
Cyprus 1077 AMINOALKYL FURAN DERIVATIVES ⤷  Try a Trial
Spain 470836 ⤷  Try a Trial
Singapore 21892 ⤷  Try a Trial
Denmark 148258 ⤷  Try a Trial
Philippines 21761 PHARMACEUTICAL COMPOSITION CONTAINING FORM 2 RANITIDINE HYDROCHLORIDE AND PROCESS OF PREPARATION THEREOF ⤷  Try a Trial
France 2491067 ⤷  Try a Trial
France 2633181 COMPOSITION PHARMACEUTIQUE A BASE DE RANITIDINE ET SON PROCEDE DE PREPARATION ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.